Skip to main content

Mutya Harsch

Equibles does not estimate personal net worth.

About Mutya Harsch

Earlier roles on record: General Counsel at Yarrow Bioscience, Inc. (YARW) until July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Mutya Harsch resigned as Chief Legal Officer and General Counsel, effective July 27, 2026. The proxy statement of Yarrow Bioscience, Inc. reports total compensation of $891,515 for Mutya Harsch in fiscal 2024, including a base salary of $443,280. Disclosed compensation is on record for 6 fiscal years. Mutya Harsch has spoken on 1 earnings call across 1 company, most recently for Yarrow Bioscience, Inc. on August 12, 2021. The companies whose calls Mutya Harsch spoke on are classified in the Healthcare sector.

“each of David Domzalski, VYNE's President and Chief Executive Officer, Iain Stuart, Ph.D., VYNE's Chief Scientific Officer, and Mutya Harsch, VYNE's Chief Legal Officer and General Counsel, resigned as executive officers at the Closing and their employment was terminated effective July 27, 2026”
Yarrow Bioscience, Inc. Form 8-K, filed July 28, 2026 · Read the filing

Mutya Harsch on recent calls

“So with respect to the Paragraph IV litigation, we obviously expected that there would be ANDA filings to AMZEEQ; this is something that's not new to this therapeutic class in particular—we knew that it was likely to come.”
General Counsel, VYNE Therapeutics Inc. Q2 FY2021 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Yarrow Bioscience, Inc. (YARW) $443,280 $891,515
2023 Yarrow Bioscience, Inc. (YARW) $382,594 $1,126,090
2022 Yarrow Bioscience, Inc. (YARW) $422,172 $654,410
2021 Yarrow Bioscience, Inc. (YARW) $405,936 $1,312,106
2020 Yarrow Bioscience, Inc. (YARW) $318,669 $907,196
2019 Yarrow Bioscience, Inc. (YARW) — —

Recent activity